dc.creatorPing, Hu
dc.creatorLeyton Campos, Lisette
dc.creatorHagood, James S.
dc.creatorBarker, Thomas H.
dc.date.accessioned2022-07-25T16:29:53Z
dc.date.accessioned2022-10-17T14:30:21Z
dc.date.available2022-07-25T16:29:53Z
dc.date.available2022-10-17T14:30:21Z
dc.date.created2022-07-25T16:29:53Z
dc.date.issued2022
dc.identifierFrontiers in Cell and Developmental Biology June 2022 Volume 10 Article 928510
dc.identifier10.3389/fcell.2022.928510
dc.identifierhttps://repositorio.uchile.cl/handle/2250/186937
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4419175
dc.description.abstractThy-1 is a cell surface glycosylphosphatidylinositol (GPI)-anchored glycoprotein that bears a broad mosaic of biological roles across various cell types. Thy-1 displays strong physiological and pathological implications in development, cancer, immunity, and tissue fibrosis. Quite uniquely, Thy-1 is capable of mediating integrin-related signaling through direct trans- and cis-interaction with integrins. Both interaction types have shown distinctive roles, even when interacting with the same type of integrin, where binding in trans or in cis often yields divergent signaling events. In this review, we will revisit recent progress and discoveries of Thy-1-integrin interactions in trans and in cis, highlight their pathophysiological consequences and explore other potential binding partners of Thy-1 within the integrin regulation/signaling paradigm.
dc.languageen
dc.publisherFrontiers Media
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/us/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States
dc.sourceFrontiers in Cell and Developmental Biology
dc.subjectIntegrin
dc.subjectThy-1 (CD90)
dc.subjectTrans-interaction
dc.subjectCis-interaction
dc.subjectSignaling
dc.subjectPathophysiology
dc.titleThy-1-integrin interactions in cis and trans mediate distinctive signaling
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución